Overexpression of the HER2 protein, a product of a proto-oncogene situated at chromosome 17, has been associated with carcinogenesis and tumor progression of breast, ovary, salivary glands, prostate and gastrointestinal tract cancers [9]. The gene discussed is ERBB2; the disease is neoplasm.